Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-16 · accession 0001668397-24-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-21 | 2024-02-16+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $390.58 | -64.0K | 5.54M | -1% | -$24.99M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | S | D | 13,988 | $386.39 | 5,525,959 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $385.00 to $389.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2024-02-16 | S | D | 50,000 | $391.75 | 5,539,947 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.06 to $394.95. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |